The females who were receiving N-9, compared to those receiving the placebo, had greater genital lesion frequency RR 1.17: 1.021.3595% CI.
Las mujeres que recibieron N-9 comparado con placebo experimentaron una mayor frecuencia de lesiones genitales RR = 1,17; IC 95% 1,02-1,35.